Dabigatran - Metabolism, Pharmacologic Properties and Drug Interactions.

@article{Antonijevi2017DabigatranM,
  title={Dabigatran - Metabolism, Pharmacologic Properties and Drug Interactions.},
  author={Neboj{\vs}a M. Antonijevi{\'c} and Ivana D. Živkovi{\'c} and Ljubica M. Jovanovi{\'c} and Dragan M. Mati{\'c} and Mladen J Kocica and Igor Bogdan Mrdovic and Vladimir I. Kanjuh and Milica D. {\'C}ulafi{\'c}},
  journal={Current drug metabolism},
  year={2017},
  volume={18 7},
  pages={622-635}
}
BACKGROUND The superiority of dabigatran has been well proven in the standard dosing regimen in prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation (NVAF) and extended venous thromboembolism (VTE) treatment. Dabigatran, an anticoagulant with a good safety profile, reduces intracranial bleeding in patients with atrial… CONTINUE READING